MDT

85.26

-0.95%↓

A

120.85

-0.66%↓

VEEV

168.97

+0.64%↑

HQY

86.11

+0.21%↑

NEOG

9.63

+1.37%↑

MDT

85.26

-0.95%↓

A

120.85

-0.66%↓

VEEV

168.97

+0.64%↑

HQY

86.11

+0.21%↑

NEOG

9.63

+1.37%↑

MDT

85.26

-0.95%↓

A

120.85

-0.66%↓

VEEV

168.97

+0.64%↑

HQY

86.11

+0.21%↑

NEOG

9.63

+1.37%↑

MDT

85.26

-0.95%↓

A

120.85

-0.66%↓

VEEV

168.97

+0.64%↑

HQY

86.11

+0.21%↑

NEOG

9.63

+1.37%↑

MDT

85.26

-0.95%↓

A

120.85

-0.66%↓

VEEV

168.97

+0.64%↑

HQY

86.11

+0.21%↑

NEOG

9.63

+1.37%↑

Search

ResMed Inc

Closed

SectorHealthcare

225.99 -0.76

Overview

Share price change

24h

Current

Min

224.25

Max

229.14

Key metrics

By Trading Economics

Income

44M

393M

Sales

87M

1.4B

P/E

Sector Avg

22.776

63.808

Dividend yield

0.99

Profit margin

27.593

Employees

10,600

EBITDA

63M

566M

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+25.68% upside

Dividends

By Dow Jones

Dividend yield

Sector Avg

0.99%

2.38%

Next Earnings

30 kwi 2026

Next Dividend date

11 cze 2026

Next Ex Dividend date

7 maj 2026

Market Stats

By TradingEconomics

Market Cap

-3.7B

34B

Previous open

226.75

Previous close

225.99

News Sentiment

By Acuity

20%

80%

55 / 348 Ranking in Healthcare

ResMed Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

20 kwi 2026, 23:49 UTC

Major News Events

New Zealand 1Q Inflation Higher Than Expected

20 kwi 2026, 23:10 UTC

Hot Stocks

Stocks to Watch: Amazon, Alaska Air Group, BridgeBio Oncology, AXT

20 kwi 2026, 22:53 UTC

Major Market Movers

BridgeBio Oncology Shares Rise After FDA Fast-Tracks Pancreatic Cancer Treatment

20 kwi 2026, 23:45 UTC

Market Talk

Nikkei May Rise on Hopes for U.S.-Iran Peace Talks -- Market Talk

20 kwi 2026, 23:44 UTC

Market Talk

Gold Consolidates as End of Cease-Fire Looms -- Market Talk

20 kwi 2026, 23:39 UTC

Market Talk

Rio Tinto Posts Strong Start to Year -- Market Talk

20 kwi 2026, 23:30 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

20 kwi 2026, 23:30 UTC

Market Talk

Global Equities Roundup: Market Talk

20 kwi 2026, 23:30 UTC

Market Talk

Super Retail's Earnings Outlook Less Rosy -- Market Talk

20 kwi 2026, 23:09 UTC

Market Talk

Viva Energy's Refinery Fire More Benign Than Jefferies Thought -- Market Talk

20 kwi 2026, 22:31 UTC

Acquisitions, Mergers, Takeovers

Anthropic, Amazon Tighten Bond in $5 Billion Investment and Computing Deal -- WSJ

20 kwi 2026, 22:26 UTC

Acquisitions, Mergers, Takeovers

West African Resources Says Sanbrado, Toega Operations Not Subject to Govt Request for Additional Participation

20 kwi 2026, 22:25 UTC

Acquisitions, Mergers, Takeovers

West African Resources Plans to Distribute Cash Proceeds to Shareholders Via Special Dividend

20 kwi 2026, 22:25 UTC

Acquisitions, Mergers, Takeovers

West African Resources Aims for Acquisition to Be Completed by End-2026

20 kwi 2026, 22:25 UTC

Acquisitions, Mergers, Takeovers

West African Resources Says to Work Cooperatively With Govt to Finalize Deal Terms

20 kwi 2026, 22:25 UTC

Acquisitions, Mergers, Takeovers

West African Resources Says Acquisition Would Be for A$175 Million

20 kwi 2026, 22:24 UTC

Acquisitions, Mergers, Takeovers

West African Resources Says Burkina Faso Govt Issues Decree to Acquire 25% of Kiaka

20 kwi 2026, 22:15 UTC

Acquisitions, Mergers, Takeovers

Anthropic, Amazon Tighten Bond in $5 Billion Investment and Computing Deal -- WSJ

20 kwi 2026, 22:01 UTC

Acquisitions, Mergers, Takeovers

Amazon Invests $5B in Anthropic Amid Expanded Collaboration

20 kwi 2026, 21:38 UTC

Market Talk

Apple's New CEO Will Face Immediate Pressure on AI Strategy -- Market Talk

20 kwi 2026, 21:33 UTC

Acquisitions, Mergers, Takeovers

Uber Expands Stake In Lucid for Robo-Taxis. This Is How Tesla's Stock Is Responding. -- Barrons.com

20 kwi 2026, 21:24 UTC

Market Talk

Apple's CEO Change Timing Will Garner Mixed Reaction, Analyst Says -- Market Talk

20 kwi 2026, 21:24 UTC

Market Talk

Global Equities Roundup: Market Talk

20 kwi 2026, 21:13 UTC

Earnings

Alaska Air: Expansion of Card Portfolio Expected to Accelerate Loyalty Platform Beyond Incremental $150M Profit Outlined in Alaska Accelerate Strategy

20 kwi 2026, 21:10 UTC

Earnings

Alaska Air to Move Toward a Single Issuer for Atmos Rewards Credit Cards

20 kwi 2026, 21:09 UTC

Earnings

Alaska Air Sees 2Q Capacity Up About 1% Year-Over-Year, Down Nearly a Point From Original Views, on 'Proactive Trimming' of May and June Capacity

20 kwi 2026, 21:08 UTC

Earnings

Alaska Air 'Continues to Operate From a Position of Strength,' With Healthy Balance Sheet, Strong Liquidity, About $20B in Unencumbered Assets

20 kwi 2026, 21:07 UTC

Earnings

Alaska Air: Taken Together, Rev, Cost and Fuel Assumptions Result in 2Q Adjusted Loss Per Share Estimate of About $1

20 kwi 2026, 21:05 UTC

Earnings

Alaska Air: This Assumption Adds About $600M of Expense to 2Q, Equivalent to EPS Headwind of $3.60

20 kwi 2026, 21:05 UTC

Earnings

Alaska Air Expects 2Q Fuel Cost to Average About $4.50 Based on Forward Curve Today

Peer Comparison

Price change

ResMed Inc Forecast

Price Target

By TipRanks

25.68% upside

12 Months Forecast

Average 286.7 USD  25.68%

High 340 USD

Low 255 USD

Based on 13 Wall Street analysts offering 12 month price targets forResMed Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

13 ratings

8

Buy

5

Hold

0

Sell

Sentiment

By Acuity

55 / 348 Ranking in Healthcare

News Sentiment

Very Strong Bullish Evidence

Volatility

Below average

News Volume (RCV)

Above average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About ResMed Inc

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; and NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry over several nights. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME) to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies; and MEDIFOX DAN's software solutions. The company markets its products to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
help-icon Live chat